• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Receptor-type protein tyrosine phosphatase beta (RPTP-beta) directly dephosphorylates and regulates hepatocyte growth factor receptor (HGFR/Met) function.受体型蛋白酪氨酸磷酸酶β(RPTP-β)可直接使肝细胞生长因子受体(HGFR/Met)去磷酸化并调节其功能。
J Biol Chem. 2011 May 6;286(18):15980-8. doi: 10.1074/jbc.M110.212597. Epub 2011 Mar 15.
2
Receptor-type protein-tyrosine phosphatase-kappa regulates epidermal growth factor receptor function.受体型蛋白酪氨酸磷酸酶κ调节表皮生长因子受体功能。
J Biol Chem. 2005 Dec 30;280(52):42694-700. doi: 10.1074/jbc.M507722200. Epub 2005 Oct 31.
3
Receptor-type Protein tyrosine phosphatase β regulates met phosphorylation and function in head and neck squamous cell carcinoma.受体型蛋白酪氨酸磷酸酶β调控头颈部鳞状细胞癌中的 MET 磷酸化和功能。
Neoplasia. 2012 Nov;14(11):1015-22. doi: 10.1593/neo.12870.
4
Receptor type protein tyrosine phosphatase-kappa mediates cross-talk between transforming growth factor-beta and epidermal growth factor receptor signaling pathways in human keratinocytes.受体型蛋白酪氨酸磷酸酶 κ 在人角质形成细胞中介导转化生长因子-β和表皮生长因子受体信号通路的串扰。
Mol Biol Cell. 2010 Jan 1;21(1):29-35. doi: 10.1091/mbc.e09-08-0710. Epub 2009 Oct 28.
5
Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells.乳腺肿瘤激酶和细胞外信号调节激酶 5 介导了乳腺癌细胞中 Met 受体信号向细胞迁移的作用。
Breast Cancer Res. 2010;12(4):R60. doi: 10.1186/bcr2622. Epub 2010 Aug 5.
6
Allosteric peptide activators of pro-hepatocyte growth factor stimulate Met signaling.变构肽激活物促进原肝生长因子刺激 Met 信号。
J Biol Chem. 2010 Dec 17;285(51):40362-72. doi: 10.1074/jbc.M110.179721. Epub 2010 Oct 11.
7
Enhanced expression and phosphorylation of the MET oncoprotein by glioma-specific PTPRZ1-MET fusions.胶质瘤特异性PTPRZ1-MET融合蛋白导致MET癌蛋白表达增强及磷酸化
FEBS Lett. 2015 Jun 4;589(13):1437-43. doi: 10.1016/j.febslet.2015.04.032. Epub 2015 Apr 29.
8
Contact inhibition of hepatocyte growth regulated by functional association of the c-Met/hepatocyte growth factor receptor and LAR protein-tyrosine phosphatase.由c-Met/肝细胞生长因子受体与LAR蛋白酪氨酸磷酸酶的功能关联调节的肝细胞生长接触抑制。
J Biol Chem. 2006 Mar 31;281(13):8765-72. doi: 10.1074/jbc.M512298200. Epub 2006 Jan 16.
9
Pleiotrophin signals increased tyrosine phosphorylation of beta beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta.多效生长因子通过使受体型蛋白酪氨酸磷酸酶β/ζ的内在催化活性失活,发出增加β-连环蛋白酪氨酸磷酸化的信号。
Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2603-8. doi: 10.1073/pnas.020487997.
10
Involvement of c-Met/hepatocyte growth factor pathway in cholangiocarcinoma cell invasion and its therapeutic inhibition with small interfering RNA specific for c-Met.c-Met/肝细胞生长因子信号通路在胆管癌细胞侵袭中的作用及其通过c-Met特异性小干扰RNA的治疗性抑制
J Surg Res. 2006 Nov;136(1):78-84. doi: 10.1016/j.jss.2006.05.031. Epub 2006 Sep 1.

引用本文的文献

1
Retracted Article: RNA-sequencing identified miR-3681 as a negative regulator in the proliferation and migration of cervical cancer cells the posttranscriptional suppression of HGFR.撤回文章:RNA测序鉴定出miR-3681是子宫颈癌细胞增殖和迁移的负调控因子,对HGFR进行转录后抑制。
RSC Adv. 2019 Jul 18;9(39):22376-22383. doi: 10.1039/c9ra01785b. eCollection 2019 Jul 17.
2
MET targeting: time for a rematch.MET 靶向治疗:是时候重新较量了。
Oncogene. 2020 Apr;39(14):2845-2862. doi: 10.1038/s41388-020-1193-8. Epub 2020 Feb 7.
3
Disrupting the transmembrane domain-mediated oligomerization of protein tyrosine phosphatase receptor J inhibits EGFR-driven cancer cell phenotypes.破坏跨膜结构域介导的蛋白酪氨酸磷酸酶受体 J 寡聚化可抑制表皮生长因子受体驱动的癌细胞表型。
J Biol Chem. 2019 Dec 6;294(49):18796-18806. doi: 10.1074/jbc.RA119.010229. Epub 2019 Nov 1.
4
The Impact of the Epithelial-Mesenchymal Transition Regulator Hepatocyte Growth Factor Receptor/Met on Skin Immunity by Modulating Langerhans Cell Migration.上皮-间充质转化调节因子肝细胞生长因子受体/Met 通过调节朗格汉斯细胞迁移对皮肤免疫的影响。
Front Immunol. 2018 Mar 16;9:517. doi: 10.3389/fimmu.2018.00517. eCollection 2018.
5
Physiological Signaling and Structure of the HGF Receptor MET.肝细胞生长因子受体MET的生理信号传导与结构
Biomedicines. 2014 Dec 31;3(1):1-31. doi: 10.3390/biomedicines3010001.
6
Activation of FGF receptor signaling promotes invasion of non-small-cell lung cancer.成纤维细胞生长因子(FGF)受体信号的激活促进非小细胞肺癌的侵袭。
Tumour Biol. 2015 May;36(5):3637-42. doi: 10.1007/s13277-014-3001-y. Epub 2015 Jan 8.
7
Inhibition of fibroblast growth factor receptor signaling impairs metastasis of hepatocellular carcinoma.抑制成纤维细胞生长因子受体信号传导会损害肝细胞癌的转移。
Tumour Biol. 2014 Nov;35(11):11005-11. doi: 10.1007/s13277-014-2384-0. Epub 2014 Aug 5.
8
Receptor-type protein tyrosine phosphatase κ directly dephosphorylates CD133 and regulates downstream AKT activation.受体型蛋白酪氨酸磷酸酶κ直接使CD133去磷酸化并调节下游AKT激活。
Oncogene. 2015 Apr 9;34(15):1949-60. doi: 10.1038/onc.2014.141. Epub 2014 Jun 2.
9
Role of met axis in head and neck cancer.中轴骨在头颈部肿瘤中的作用。
Cancers (Basel). 2013 Nov 26;5(4):1601-18. doi: 10.3390/cancers5041601.
10
Hydroxyindole carboxylic acid-based inhibitors for receptor-type protein tyrosine protein phosphatase beta.用于受体型蛋白酪氨酸磷酸酶β的基于羟基吲哚羧酸的抑制剂。
Antioxid Redox Signal. 2014 May 10;20(14):2130-40. doi: 10.1089/ars.2013.5463. Epub 2014 Feb 4.

本文引用的文献

1
Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC.MET 扩增在 EGFR 突变 NSCLC 中的预先存在和克隆选择。
Cancer Cell. 2010 Jan 19;17(1):77-88. doi: 10.1016/j.ccr.2009.11.022.
2
The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis.肝细胞生长因子/c-Met信号通路作为抑制血管生成的治疗靶点。
BMB Rep. 2008 Dec 31;41(12):833-9. doi: 10.5483/bmbrep.2008.41.12.833.
3
Tyrosine phosphatase beta regulates angiopoietin-Tie2 signaling in human endothelial cells.酪氨酸磷酸酶β调节人内皮细胞中的血管生成素-Tie2信号通路。
Angiogenesis. 2009;12(1):25-33. doi: 10.1007/s10456-008-9126-0. Epub 2009 Jan 1.
4
HER kinase activation confers resistance to MET tyrosine kinase inhibition in MET oncogene-addicted gastric cancer cells.HER激酶激活赋予对MET致癌基因成瘾的胃癌细胞中MET酪氨酸激酶抑制的抗性。
Mol Cancer Ther. 2008 Nov;7(11):3499-508. doi: 10.1158/1535-7163.MCT-08-0374. Epub 2008 Oct 30.
5
Regulation of the Met receptor-tyrosine kinase by the protein-tyrosine phosphatase 1B and T-cell phosphatase.蛋白酪氨酸磷酸酶1B和T细胞磷酸酶对Met受体酪氨酸激酶的调控
J Biol Chem. 2008 Dec 5;283(49):34374-83. doi: 10.1074/jbc.M805916200. Epub 2008 Sep 26.
6
The Met tyrosine kinase receptor in development and cancer.发育与癌症中的Met酪氨酸激酶受体
Cancer Metastasis Rev. 2008 Mar;27(1):85-94. doi: 10.1007/s10555-007-9107-6.
7
A selective small molecule inhibitor of c-Met, PHA665752, inhibits tumorigenicity and angiogenesis in mouse lung cancer xenografts.一种选择性的c-Met小分子抑制剂PHA665752可抑制小鼠肺癌异种移植瘤的致瘤性和血管生成。
Cancer Res. 2007 Apr 15;67(8):3529-34. doi: 10.1158/0008-5472.CAN-06-4416.
8
c-Met is essential for wound healing in the skin.c-Met对皮肤伤口愈合至关重要。
J Cell Biol. 2007 Apr 9;177(1):151-62. doi: 10.1083/jcb.200701086. Epub 2007 Apr 2.
9
Vascular endothelial tyrosine phosphatase (VE-PTP)-null mice undergo vasculogenesis but die embryonically because of defects in angiogenesis.血管内皮酪氨酸磷酸酶(VE-PTP)基因敲除小鼠可进行血管生成,但由于血管生成缺陷在胚胎期死亡。
Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3243-8. doi: 10.1073/pnas.0611510104. Epub 2007 Feb 21.
10
From Tpr-Met to Met, tumorigenesis and tubes.从Tpr-Met到Met,肿瘤发生与血管生成。 (注:这里“tubes”结合语境推测可能是“血管生成”之类的意思,具体准确含义需结合更多背景知识确定)
Oncogene. 2007 Feb 26;26(9):1276-85. doi: 10.1038/sj.onc.1210201.

受体型蛋白酪氨酸磷酸酶β(RPTP-β)可直接使肝细胞生长因子受体(HGFR/Met)去磷酸化并调节其功能。

Receptor-type protein tyrosine phosphatase beta (RPTP-beta) directly dephosphorylates and regulates hepatocyte growth factor receptor (HGFR/Met) function.

机构信息

Department of Dermatology, University of Michigan Medica School, Ann Arbor, MI 48109-5609, USA.

出版信息

J Biol Chem. 2011 May 6;286(18):15980-8. doi: 10.1074/jbc.M110.212597. Epub 2011 Mar 15.

DOI:10.1074/jbc.M110.212597
PMID:21454675
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3091207/
Abstract

Protein tyrosine phosphorylation is a ubiquitous, fundamental biochemical mechanism that regulates essential eukaryotic cellular functions. The level of tyrosine phosphorylation of specific proteins is finely tuned by the dynamic balance between protein tyrosine kinase and protein tyrosine phosphatase activities. Hepatocyte growth factor receptor (also known as Met), a receptor protein tyrosine kinase, is a major regulator of proliferation, migration, and survival for many epithelial cell types. We report here that receptor-type protein tyrosine phosphatase β (RPTP-β) specifically dephosphorylates Met and thereby regulates its function. Expression of RPTP-β, but not other RPTP family members or catalytically inactive forms of RPTP-β, reduces hepatocyte growth factor (HGF)-stimulated Met tyrosine phosphorylation in HEK293 cells. Expression of RPTP-β in primary human keratinocytes reduces both basal and HGF-induced Met phosphorylation at tyrosine 1356 and inhibits downstream MEK1/2 and Erk activation. Furthermore, shRNA-mediated knockdown of endogenous RPTP-β increases basal and HGF-stimulated Met phosphorylation at tyrosine 1356 in primary human keratinocytes. Purified RPTP-β intracellular domain preferentially dephosphorylates purified Met at tyrosine 1356 in vitro. In addition, the substrate-trapping mutant of RPTP-β specifically interacts with Met in intact cells. Expression of RPTP-β in human primary keratinocytes reduces HGF induction of VEGF expression, proliferation, and motility. Taken together, the above data indicate that RPTP-β is a key regulator of Met function.

摘要

蛋白质酪氨酸磷酸化是一种普遍存在的基本生化机制,调节着真核细胞的基本功能。特定蛋白质的酪氨酸磷酸化水平通过蛋白酪氨酸激酶和蛋白酪氨酸磷酸酶活性之间的动态平衡来精细调节。肝细胞生长因子受体(也称为 Met),一种受体蛋白酪氨酸激酶,是许多上皮细胞类型增殖、迁移和存活的主要调节因子。我们在这里报告,受体型蛋白酪氨酸磷酸酶β(RPTP-β)特异性地使 Met 去磷酸化,从而调节其功能。RPTP-β的表达,而不是其他 RPTP 家族成员或无催化活性的 RPTP-β形式,降低了 HEK293 细胞中肝细胞生长因子(HGF)刺激的 Met 酪氨酸磷酸化。RPTP-β在原代人角质形成细胞中的表达降低了基础和 HGF 诱导的 Met 在酪氨酸 1356 处的磷酸化,并抑制下游 MEK1/2 和 Erk 的激活。此外,shRNA 介导的内源性 RPTP-β 的敲低增加了原代人角质形成细胞中基础和 HGF 刺激的 Met 在酪氨酸 1356 处的磷酸化。纯化的 RPTP-β 细胞内结构域在体外优先使纯化的 Met 在酪氨酸 1356 处去磷酸化。此外,RPTP-β 的底物捕获突变体在完整细胞中特异性地与 Met 相互作用。RPTP-β在人原代角质形成细胞中的表达降低了 HGF 诱导的 VEGF 表达、增殖和迁移。综上所述,上述数据表明 RPTP-β 是 Met 功能的关键调节因子。